Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
May/June 2010, Vol 3, No 3
Clinical
Prevalence of Treated Bipolar Disorders and Associated Comorbidities in Managed Care and Medicaid Populations
Jeff Jianfei Guo, BPharm, PhD
,
Nick C. Patel, PharmD, PhD
,
Hong Li, PhD
,
Paul E. Keck Jr., MD
Stakeholder Perspective
Bipolar Disorder Prevalence Often Underestimated
by
Nirav R. Shah, MD,MPH
Read More
Business
Health Benefit Coverage, Reimbursement, and Influences on Traditional Pharmaceutical Channels
F. Randy Vogenberg, PhD, FASHP
Stakeholder Perspective
The Many Challenges of Pay-for-Performance Programs
by
Gary M. Owens, MD
Read More
Business
Impact of Etanercept Treatment on Absenteeism and Productivity: The Work Loss and Productivity Survey
Denise Globe, PhD
,
Peter Mazonson, MD, MBA
,
Chris Santas, MBA
,
Regina Murphy, MBA
,
Annie Cheng
,
Xingyue Huang, PhD
,
Arthur Kavanaugh, MD
Stakeholder Perspective
What Is the Value of Specialty Pharmaceuticals?
Read More
1
2
Page 2 of 2
Results 11 - 13 of 13